ActiveNCT07148349

Artificial Intelligence in Trapeziometacarpal Joint Osteoarthritis: Improving Assessment and Clinical Decision-Making

Sponsor: Schulthess Klinik

Trial Details

ConditionThumb Osteoarthritis
InterventionNo Intervention: Observational Cohort
StatusActive
Participants2,500
Est. Completion1 Aug 2028
Last Updated30 Apr 2026

Primary Outcome

New TMC OA classification; Automation of the new TMC OA classification; Automated implant migration detection; 3D reconstruction of the TMC joint

Eligibility Criteria

Inclusion Criteria

Inclusion criteria: Patients will be included in the study if they have provided written general consent for the use of their clinical data and meet the requirements of one of the following two groups: TMC OA group: • Patients who received a Touch implant for TMC joint arthroplasty and are documented in our clinical registry Other clinical conditions: • Patients who underwent radiographic imaging for one of the following conditions, with a clearly visible TMC joint, for example: Distal radius fracture, carpal fracture, finger dislocation, or similar. Exclusion Criteria: The exclusion criteria are defined based on the two inclusion groups: TMC OA group: * Patients with posttraumatic OA. * Patients with rheumatoid arthritis. Other clinical conditions: * Eaton Littler score higher than one. * Prior surgery affecting the trapezium or the first metacarpal. * Clinical condition resulting in abnormal TMC joint morphology. Furthermore, patients will also be excluded if they revoke their consent in writing or via verbal withdrawal.

Trial Sites

Countries

Switzerland
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service